medigraphic.com

2003, Number 2

<< Back Next >>

Enf Infec Microbiol 2003; 23 (2)

Hydrocephalus, ventricular derivation and ependimitis (Part II)

Díaz PC, López VGA, Diegopérez RJ, Palacios SG

Language: Spanish
References: 15
Page: 44-49
PDF size: 62.53 Kb.


ABSTRACT

In this article we comment about frequency, etiology. Risk factors and pathogenesis of ventricular ependimitis (VE), which the more frequent and severe complication of derivative systems in hydrocephalus. We describe also the clinical manifestations, specific treatment and complications.


REFERENCES

  1. Tatsuno M, Hasegawa M, Okuyama K. Ventriculitis in infants. Pediatr Neurol 1993;9:127-30.

  2. Hanekom WA, Yogev R. Cerebrospinal fluid infections. Advan Pediatr Infect Dis 1996;11:29-54.

  3. Kulkarni AV, Drake JM, Lamberti-Pasculli M. Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg 2001;94:195-201.

  4. Pople IK, Bayston R, Hayward R. Infection of cerebrospinal fluid shunts in infants: a study of etiological factors. J. Neurosurg. 1992; 77: 29-36.

  5. Asi-Bautista MC, Heidemann SM, Meert KL, Canady AI, Sarnaik AP. Tumor necrosis factor-a, interleukin-1ß, and interleukin-6 concentrations in cerebrospinal fluid predict ventriculoperitoneal shunt infection. Crit Care Med 1997;25:1713-1716.

  6. Tunkel AR, Scheld WM. Acute bacterial meningitis. Lancet 1995;346:1675-1680.

  7. Guevara JA, Zuccaro G, Trevisan A, Denova CD. Bacterial adhesion to cerebrospinal fluid shunts. J Neurosurg 1987;67:438-445.

  8. Andranik M, Conway E. Cerebrospinal fluid shunt problems in pediatric patients. Pediatr Annals 1997;26:613-620.

  9. Domínguez AH, Miranda NMG. Efectividad del tratamiento antimicrobiano intraventricular en ependimitis ventricular asociada a sistema derivativo de líquido cefalorraquídeo. Tesis de postgrado. México, 2001.

  10. López-Cortés LF, Marquéz-Arbizu R, Jiménez-Jiménez LM, Jiménez-Mejía E, Caballero-Granado FJ et al. Cerebrospinal fluid tumor necrosis factor-a, interleukin 1-ß, interleukin-6, and interleukin-8 as diagnostic markers of cerebrospinal fluid infection in neurosurgical patients. Crit Care Med 2000;28:215-219.

  11. López-Cortés LF, Cruz-Ruiz M, Gómez-mateos J, Jiménez-Hernández D, Palomino J, Jiménez E. Measurement of levels of Tumor Necrosis Factor- a and Interleukin 1-ß in the CSF of patients with meningitis of different etiologies: utility in the differential diagnosis. Clin Infect Dis 1993;16:534-539.

  12. Ronan A, Hogg GH. Cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J 1995;14:782-786.

  13. Lutsar I, McCracken GH, Friedland IR. Antibiotic pharmacodynamics in cerebrospinal fluid. Clin Infect Dis J 1998;27:1 117-1129.

  14. Kearney BP, Aweka FT. The penetration of anti-inefective into the central nervous system. Neurol Clin North Am 1999;17:4.

  15. James HE, Walsh JW, Wilson HD, CONNOR JD, Bean JR, Tibbs PA. Prospective randomized study of therapy in cerebrospinal fluid shunt infection. Neurosurgery 1980;7:459-63.




2020     |     www.medigraphic.com